These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 6661617

  • 1. A subcortico-cortical cholinergic system is affected in Parkinson's disease.
    Dubois B, Ruberg M, Javoy-Agid F, Ploska A, Agid Y.
    Brain Res; 1983 Dec 12; 288(1-2):213-8. PubMed ID: 6661617
    [Abstract] [Full Text] [Related]

  • 2. Muscarinic binding and choline acetyltransferase activity in Parkinsonian subjects with reference to dementia.
    Ruberg M, Ploska A, Javoy-Agid F, Agid Y.
    Brain Res; 1982 Jan 28; 232(1):129-39. PubMed ID: 7055689
    [Abstract] [Full Text] [Related]

  • 3. Muscarinic receptor plasticity in rats lesioned in the nucleus basalis of Meynert.
    Vige X, Briley M.
    Neuropharmacology; 1989 Jul 28; 28(7):727-32. PubMed ID: 2761681
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Altered muscarinic and nicotinic receptor densities in cortical and subcortical brain regions in Parkinson's disease.
    Lange KW, Wells FR, Jenner P, Marsden CD.
    J Neurochem; 1993 Jan 28; 60(1):197-203. PubMed ID: 8417140
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Dementia and Parkinson's disease: biochemical and anatomo-clinical correlation].
    Dubois B, Hauw JJ, Ruberg M, Serdaru M, Javoy-Agid F, Agid Y.
    Rev Neurol (Paris); 1985 Jan 28; 141(3):184-93. PubMed ID: 4001706
    [Abstract] [Full Text] [Related]

  • 9. Scopolamine induces up-regulation of nicotinic receptors in intact brain but not in nucleus basalis lesioned rats.
    Vige X, Briley M.
    Neurosci Lett; 1988 Jun 07; 88(3):319-24. PubMed ID: 3386878
    [Abstract] [Full Text] [Related]

  • 10. Dopaminergic and cholinergic lesions in progressive supranuclear palsy.
    Ruberg M, Javoy-Agid F, Hirsch E, Scatton B, LHeureux R, Hauw JJ, Duyckaerts C, Gray F, Morel-Maroger A, Rascol A.
    Ann Neurol; 1985 Nov 07; 18(5):523-9. PubMed ID: 3000280
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Decreased muscarinic receptor binding in cerebral cortex and hippocampus in Alzheimer's disease.
    Reinikainen KJ, Riekkinen PJ, Halonen T, Laakso M.
    Life Sci; 1987 Jul 27; 41(4):453-61. PubMed ID: 3600187
    [Abstract] [Full Text] [Related]

  • 13. Aging and brain cholinergic muscarinic receptors: an autoradiographic study in the rat.
    Biegon A, Duvdevani R, Greenberger V, Segal M.
    J Neurochem; 1988 Nov 27; 51(5):1381-5. PubMed ID: 3171584
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Effects of bilateral ibotenate-induced lesions of the nucleus basalis magnocellularis upon selective cholinergic biochemical markers in the rat anterior cerebral cortex.
    Watson M, Vickroy TW, Fibiger HC, Roeske WR, Yamamura HI.
    Brain Res; 1985 Nov 04; 346(2):387-91. PubMed ID: 3840399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Clinical and neurochemical consequences of neuronal loss in the nucleus basalis of Meynert in Parkinson's disease and Alzheimer's disease.
    Whitehouse PJ.
    Adv Neurol; 1987 Nov 04; 45():393-7. PubMed ID: 2881448
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.